drugset / Trial / NCT01834053

Safety and Efficacy of Bone Marrow Derived MNCs for Treatment of Cells for the Treatment of Hunting Tons Chorea.

NCT01834053 ↗

Phase 1/2 Unknown 50 enrolled Chaitanya Hospital, Pune
NaSingle-groupOpen-labelTreatment

Summary

This study is Single arm, Single Centre trial to check the Safety and Efficacy of Bone Marrow Derived Autologous mononuclear cell {MNC} (100 Million per dose).trial to be conducted for 36 months in patients with diabetes Mellitus in India,Primary outcome measure are Improvement in cognitive and Psychiatric Symptoms and Improvement in Jerky,random, and Uncontrollable Movements called Chorea.

Timeline

Start
2014-09
Primary completion
2016-06
Completion
2016-06

Drugs

EvaluationDrugModalityDoseRoute
Subject autologous Stem Cell Unknown 1e+08 cells Intrathecal

Indications